Who are DTacP's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): LMB C, LMB B.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dtacp.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

DTacP — Competitive Intelligence Brief

DTacP (DTacP) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunotoxin. Area: Oncology.

phase 3 Immunotoxin Oncology Biologic Live · refreshed every 30 min

Target snapshot

DTacP (DTacP) — Changchun BCHT Biotechnology Co.. DTacP is a diphtheria toxin-based immunotoxin that targets and eliminates cells expressing specific tumor-associated antigens.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
DTacP TARGET	DTacP	Changchun BCHT Biotechnology Co.	phase 3	Immunotoxin
LMB C	LMB C	Gustave Roussy, Cancer Campus, Grand Paris	phase 3	Immunotoxin	CD25 (IL-2 receptor alpha chain)
LMB B	LMB B	Gustave Roussy, Cancer Campus, Grand Paris	phase 3	Immunotoxin	CD25 (IL-2 receptor alpha chain)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunotoxin class)

Gustave Roussy, Cancer Campus, Grand Paris · 2 drugs in this class
Changchun BCHT Biotechnology Co. · 1 drug in this class
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DTacP — Competitive Intelligence Brief. https://druglandscape.com/ci/dtacp. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab